Fig. 2
From: The “RCT augmentation”: a novel simulation method to add patient heterogeneity into phase III trials
Calculation of comparative efficacy of drug D1 vs. D2 obtained from virtual Phase III RCTs. This calculation is repeated for each type of RCT population augmentation (= each relaxed criterion)